U.S. Chemicals Stock News

XPeng (XPEV) moved into focus after its half year 2026 results showed revenue of CNY 32,777.37 million and a larger net loss. Fresh third quarter guidance added another layer for investors to assess. See our latest analysis for XPeng. XPeng’s latest earnings release and guidance come against a weak recent share price trend, with the stock at US$12.19 and a 90 day share price return that declined 26.34%, while the 1 year total shareholder return fell 47.16%. If XPeng’s results have you...

Aurinia Pharmaceuticals has delivered a 82.4% return over the past three years, which puts fresh attention on whether the current US$16.65 share price still reflects good value or if expectations have already been priced in. Valuation checks currently lean positive, so recent gains raise a fair question about how much upside may be left. The 82.4% three year return suggests investors who backed Aurinia Pharmaceuticals over that period have already been rewarded, which can raise the bar for...

We wouldn't blame Tempus AI, Inc. ( NASDAQ:TEM ) shareholders if they were a little worried about the fact that Eric...

We wouldn't blame WESCO International, Inc. ( NYSE:WCC ) shareholders if they were a little worried about the fact that...

Some Arrowhead Pharmaceuticals, Inc. ( NASDAQ:ARWR ) shareholders may be a little concerned to see that the Independent...

Digital Turbine stock has rallied strongly over the past year, yet the market’s current read on its valuation suggests the shares may now be closer to fairly priced than obviously cheap. For investors, the puzzle is how to square that performance with what the broader valuation checks are indicating today. Over the last 12 months, Digital Turbine has returned 165.1%, which places extra weight on whether the current share price leaves much room for further upside. The company’s ability to...

Strategy stock has rebounded sharply over the past few years, yet its recent value checks still suggest the shares are not an obvious bargain. With a long term Bitcoin accumulation plan, index inclusion questions and sharp swings in crypto sentiment, investors are trying to work out how much of Strategy’s complex story is already reflected in the current price. Strategy has returned 246.3% over the past 3 years, which puts recent weakness into context but also raises the bar for what counts...

Archer Aviation (NYSE:ACHR) announced a partnership with AEG to build downtown Los Angeles' first vertiport at L.A. LIVE ahead of the LA28 Olympic Games. The agreement makes Archer the exclusive air taxi provider for the L.A. LIVE entertainment and sports district. The planned vertiport is intended to serve as a central hub within Archer's wider Los Angeles air taxi network. The project supports Archer's role as the Official Air Taxi Provider for the LA28 Games and signals progress toward...

Earlier in August 2026, Netlist, Inc. launched new patent infringement actions at the U.S. International Trade Commission and in California federal court against Micron, Supermicro, Hewlett Packard Enterprise, and Lenovo over DDR5 RDIMM and MRDIMM technologies. These legal challenges arrive just as Hewlett Packard Enterprise showcases its AI-focused infrastructure roadmap and reinforces its position in enterprise storage, creating a tension between technology momentum and patent risk. We'll...

U.S. Bancorp stock has almost doubled over the past three years, yet the current valuation checks still point to a discount, with both the intrinsic value estimate from the Excess Returns model and the market multiples suggesting the shares trade below their assessed worth. U.S. Bancorp has delivered a 96.8% total return over three years, which puts recent share price strength against a valuation framework that still flags upside. The valuation can be supported by the bank's ability to...

Zimmer Biomet Holdings (ZBH) has drawn fresh investor attention following recent share price gains over the past month and the past three months, prompting a closer look at how its current valuation aligns with its fundamentals. See our latest analysis for Zimmer Biomet Holdings. At the latest share price of US$100.98, Zimmer Biomet Holdings has seen strong short term momentum, with a 30 day share price return of 10.54% and a 90 day share price return of 19.63%, even though the 1 year total...

Adobe recently raised its fiscal 2026 revenue and earnings guidance, pointing to strong uptake of AI-powered tools such as Firefly, Acrobat AI Assistant and newer web-based agents, while also announcing an acquisition in image enhancement and fresh enterprise training initiatives. The combination of upgraded guidance, expanding AI product adoption and growing institutional interest has sharpened attention on how Adobe is balancing heavy AI investment with the need to improve billings growth...

Lincoln Electric Holdings, Inc. disclosed that on August 28, 2026, Michael J. Whitehead resigned as Executive Vice President and President of Americas Welding, with interim leadership now shared by senior executives Gary Konarska and Albert Castillo. For investors, this leadership transition in the sizeable Americas Welding business raises questions about management continuity at a time when execution on automation and premium product initiatives is central to the company’s long-term...

Recent commentary on Trade Desk (TTD) has turned cautious, with analysts flagging slower projected sales and higher capital needs, even as the company rolls out new tools like Audience Unlimited and Zuma while targeting midsize advertisers. See our latest analysis for Trade Desk. Trade Desk's recent tools and measurement upgrades come against a weak share price backdrop, with the stock down 23.8% on a 30 day share price return and the 1 year total shareholder return declining 74.8%. This...

Celsius Holdings stock has had a rough three year run, with the valuation picture now split between an intrinsic value estimate that flags a large discount and market multiples that look demanding. On top of that, recent leadership changes and an investor investigation keep the focus on how much risk is already reflected in today’s US$33.36 share price. The share price has declined 45.1% over the past three years, which raises the bar for any argument that Celsius Holdings is still priced...

Earlier this month, Accenture plc presented at the 5th TestMu Conference, where Managing Director of Quality Engineering Mallika Fernandes highlighted the firm’s software testing and quality engineering capabilities. While investors have been weighing Accenture’s recently lowered full-year fiscal 2026 revenue growth forecast and softer AI-related demand, this conference appearance underscores the company’s ongoing emphasis on quality engineering as part of its broader technology services...

Ecovyst Inc. has appointed Laurie Bergman as its new Chief Financial Officer and Treasurer, effective August 24, 2026, succeeding long‑time executive Michael Feehan, who will remain with the company’s subsidiary until September 30, 2026 to support the transition. Bergman’s combination of prior CFO roles and current audit committee leadership at two public companies brings extensive financial oversight experience to Ecovyst’s leadership bench at a time of ongoing portfolio and capital...

Napco Security Technologies, Inc. has reported its fourth-quarter and full-year 2026 results, with Q4 revenue rising to US$55.81 million and net income to US$17.77 million, while full-year revenue reached US$202.32 million and net income was broadly stable at US$43.03 million. The company also lifted its quarterly dividend to US$0.17 per share and highlighted strong, high-margin recurring service revenue, underscoring the growing importance of its services model alongside traditional...

Annaly Capital Management has delivered a 71.1% total return over the last three years, yet valuation checks and an intrinsic value estimate based on the Excess Returns model both point to the stock trading at a discount to what the underlying business may justify. That combination of strong medium term returns and an apparent valuation gap is the question investors are now weighing. Over the past three years, Annaly Capital Management has returned 71.1%. This puts recent price strength on...

Ultragenyx Pharmaceutical (RARE) drew fresh attention after the U.S. Food and Drug Administration granted accelerated approval for GENGLYCOS, its gene therapy for glycogen storage disease type Ia, along with a related corporate update call. See our latest analysis for Ultragenyx Pharmaceutical. The FDA approval for GENGLYCOS landed alongside a 1-day share price return of 2.01%, although the 30-day share price return is down 3.98%. Over the past year, the total shareholder return declined...

Why the Azenta CEO transition matters for shareholders The CEO shift at Azenta (AZTA), with John Marotta stepping down and board member Dr. Martin Madaus becoming interim President and CEO, puts leadership and execution firmly in focus for anyone watching the stock. This change comes as the board begins a formal search for a permanent chief executive and reiterates its existing revenue guidance. For investors, the message is that succession planning and short term business continuity are both...

The US–Canada trade dispute has turned the border into a profit and risk filter as 50% tariffs hit a wide range of goods and add new friction to every shipment. That stress on exporters could mean more work for logistics and customs specialists who help keep goods moving. This article walks through three stocks from our Trade-Friction Logistics & Customs Services screener that appear closely exposed to these cross‑border ripples. The three stocks highlighted below are just a starting sample...

In recent years, Arthur J. Gallagher (NYSE:AJG) has delivered around 20% annual revenue growth and 18.5% yearly earnings-per-share growth, supported by a 17.3% free cash flow margin that underpins reinvestment and capital returns. This combination of rapid top-line expansion, outperformance versus peers, and strong cash generation points to meaningful market share gains and operational efficiency improvements. Now we’ll explore how this strong revenue growth and resilient free cash flow...

Labcorp Holdings Inc. ( NYSE:LH ) is about to trade ex-dividend in the next 3 days. The ex-dividend date occurs one day...